Both CD4+ and CD8+ T-cells in CLL patients express high levels of interleukin-4 (IL-4)[47], upregulating the anti-apoptotic signal, BCL-2[48]. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.